These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3878392)

  • 1. Polyadenylic-polyuridylic acid: biological response-modifying activities in mice. In vivo organ distribution and pharmacokinetics in rabbits.
    Lacour F
    J Biol Response Mod; 1985 Oct; 4(5):490-4. PubMed ID: 3878392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response to alloantigens in vitro, amplification of the development of cytotoxic T lymphocytes by lipopolysaccharide and polyadenylic:polyuridylic acid.
    Narayanan PR; Kloehn DB; Sundharadas G
    J Immunol; 1978 Dec; 121(6):2502-8. PubMed ID: 152794
    [No Abstract]   [Full Text] [Related]  

  • 3. A phase I clinical tolerance study of polyadenylic-polyuridylic acid in cancer patients.
    Ducret JP; Caillé P; Sancho Garnier H; Amiel JL; Michelson M; Hovanessian AG; Youn JK; Lacour F
    J Biol Response Mod; 1985 Apr; 4(2):129-33. PubMed ID: 3998763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitor cells in spleens of mice with low natural killer activity.
    Blair PB; Staskawicz MO; Sam JS
    J Natl Cancer Inst; 1983 Sep; 71(3):571-7. PubMed ID: 6577231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of C3H/He mouse mammary tumor growth by combined treatment with cyclophosphamide and polyadenylic-polyuridylic acid.
    Youn JK; Lacour F; Hue G
    Cancer Res; 1982 Nov; 42(11):4706-11. PubMed ID: 7127305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoadjuvant effects of polyadenylic:polyuridylic acids through TLR3 and TLR7.
    Sugiyama T; Hoshino K; Saito M; Yano T; Sasaki I; Yamazaki C; Akira S; Kaisho T
    Int Immunol; 2008 Jan; 20(1):1-9. PubMed ID: 17981792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Poly A. Poly U in vivo alterations of proportions of T and B cell subsets.
    Donner M; Bischoff P; Lacour F
    Dev Biol Stand; 1977 Apr 13-15; 38():159-65. PubMed ID: 305372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of specificity for viral and H-2 antigens by anomalous T killer cells generated in murine leukocyte cultures.
    Shain B; Holt CA; Lilly F
    J Immunol; 1982 Aug; 129(2):722-9. PubMed ID: 6177779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of natural killer cell activity and 2-5A synthetase in mice treated with polyadenylic.polyuridylic acid.
    Youn JK; Hovanessian AG; Riviere Y; Hue G; Lacour F
    Cell Immunol; 1983 Jul; 79(2):298-308. PubMed ID: 6872004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-halo-6-phenyl pyrimidinones: new molecules with cancer therapeutic potential and interferon-inducing capacity are strong inducers of murine natural killer cells.
    Lotzová E; Savary CA; Stringfellow DA
    J Immunol; 1983 Feb; 130(2):965-9. PubMed ID: 6848603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
    Hanna N; Schneider M
    J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of spontaneous C3H/HeJ mammary tumorigenesis by long-term polyadenylic-polyuridylic acid therapy.
    Drake WP; Pendergrast WJ; Kramer RE; Mardiney MR
    Cancer Res; 1975 Nov; 35(11 Pt 1):3051-3. PubMed ID: 1182699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concanavalin a injection activates intrahepatic innate immune cells to provoke an antitumor effect in murine liver.
    Miyagi T; Takehara T; Tatsumi T; Suzuki T; Jinushi M; Kanazawa Y; Hiramatsu N; Kanto T; Tsuji S; Hori M; Hayashi N
    Hepatology; 2004 Nov; 40(5):1190-6. PubMed ID: 15486936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of potent antitumor natural killer cell activity by herpes simplex virus-thymidine kinase and ganciclovir therapy in an orthotopic mouse model of prostate cancer.
    Hall SJ; Sanford MA; Atkinson G; Chen SH
    Cancer Res; 1998 Aug; 58(15):3221-5. PubMed ID: 9699645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo effects of mercuric chloride on thymic endocrine activity, NK and NKT cell cytotoxicity, cytokine profiles (IL-2, IFN-gamma, IL-6): role of the nitric oxide-L-arginine pathway.
    Santarelli L; Bracci M; Mocchegiani E
    Int Immunopharmacol; 2006 Mar; 6(3):376-89. PubMed ID: 16428073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: role of cytokines.
    Pope BL; Chourmouzis E; MacIntyre JP; Lee S; Goodman MG
    Cell Immunol; 1994 Dec; 159(2):194-210. PubMed ID: 7994754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials using polyadenylic-polyuridylic acid as an adjuvant to surgery in treating different human tumors.
    Lacour J
    J Biol Response Mod; 1985 Oct; 4(5):538-43. PubMed ID: 3908619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells.
    Andrews KJ; Ribas A; Butterfield LH; Vollmer CM; Eilber FC; Dissette VB; Nelson SD; Shintaku P; Mekhoubad S; Nakayama T; Taniguchi M; Glaspy JA; McBride WH; Economou JS
    Cancer Res; 2000 Nov; 60(22):6457-64. PubMed ID: 11103813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics and pharmacological aspects of interferons].
    Kiuch Y
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):36-43. PubMed ID: 6421242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of suppressor cells in the decline of natural killer cell activity in estrogen-treated mice.
    Milisauskas VK; Cudkowicz G; Nakamura I
    Cancer Res; 1983 Nov; 43(11):5240-3. PubMed ID: 6225513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.